AU2003286555A1 - Phosphodiester inhibitors and nitric oxide modulators for treating peyronie's disease, arteriosclerosis and other fibrotic diseases - Google Patents

Phosphodiester inhibitors and nitric oxide modulators for treating peyronie's disease, arteriosclerosis and other fibrotic diseases

Info

Publication number: AU2003286555A1
Authority: AU; Australia
Prior art keywords: arteriosclerosis; disease; nitric oxide; fibrotic diseases; oxide modulators
Prior art date: 2002-10-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003286555A

Other versions

AU2003286555A8 (en

Inventor

Nestor F. Gonzalez-Cadavid

Jacob Rajfer

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center

Original Assignee

Harbor UCLA Research and Education Institute

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-22

Filing date

2003-10-21

Publication date

2004-05-13

2003-10-21 Application filed by Harbor UCLA Research and Education Institute filed Critical Harbor UCLA Research and Education Institute

2004-05-13 Publication of AU2003286555A1 publication Critical patent/AU2003286555A1/en

2004-05-13 Publication of AU2003286555A8 publication Critical patent/AU2003286555A8/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2003286555A 2002-10-22 2003-10-21 Phosphodiester inhibitors and nitric oxide modulators for treating peyronie's disease, arteriosclerosis and other fibrotic diseases Abandoned AU2003286555A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US42028102P	2002-10-22	2002-10-22
US60/420,281		2002-10-22
PCT/US2003/033400 WO2004037183A2 (en)	2002-10-22	2003-10-21	Phosphodiester inhibitors and nitric oxide modulators for treating peyronie’s disease, arteriosclerosis and other fibrotic diseases

Publications (2)

Publication Number	Publication Date
AU2003286555A1 true AU2003286555A1 (en)	2004-05-13
AU2003286555A8 AU2003286555A8 (en)	2004-05-13

Family

ID=32176545

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003286555A Abandoned AU2003286555A1 (en)	2002-10-22	2003-10-21	Phosphodiester inhibitors and nitric oxide modulators for treating peyronie's disease, arteriosclerosis and other fibrotic diseases

Country Status (2)

Country	Link
AU (1)	AU2003286555A1 (en)
WO (1)	WO2004037183A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102004038328A1 (en) *	2004-08-06	2006-03-16	Bayer Healthcare Ag	New uses of 2-phenyl-substituted imidazotriazinone derivatives
AU2005277384B2 (en)	2004-08-17	2011-11-17	The Johns Hopkins University	PDE5 inhibitor compositions and methods for treating cardiac indications
TWI339578B (en)	2004-10-29	2011-04-01	Mitsubishi Tanabe Pharma Corp	Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
RU2369392C2 (en) *	2005-06-10	2009-10-10	Донг-А Фармасьютикал. Ко., Лтд.	Pyrazolpyramidinon derivative-containing medicine for liver diseases treatment and prevention
EP2219650B1 (en)	2007-10-26	2014-05-07	Pacific Therapeutics Ltd.	Compositions and methods for treating fibroproliferative disorders
MX350145B (en)	2011-07-20	2017-08-28	Mediwound Ltd	Proteolytic extract from bromelain for the treatment of connective tissue disorders.
ES2700989T3 (en)	2012-12-21	2019-02-20	Mayo Found Medical Education & Res	Methods and materials to treat calcified aortic valve stenosis
EP3242668A4 (en) *	2015-01-06	2018-09-19	Eton Pharmaceuticals, Inc.	Pharmaceutical formulations of xanthine or xanthine derivatives
US11033549B2 (en)	2017-03-14	2021-06-15	Atir Holding S.A.	Use of heterocyclic compounds in the treatment of pigmented skin
CA3055882A1 (en)	2017-03-14	2018-09-20	Atir Holding S.A.	Topical formulation for the treatment of pigmented skin
SG11202110533RA (en)	2019-04-10	2021-10-28	Mayo Found Medical Education & Res	Methods and materials for gender-dependent treatment of cardiovascular dysfunction
CN112773898A (en) *	2019-11-11	2021-05-11	广州华真医药科技有限公司	Application of phosphodiesterase 5 inhibitor in preparing anti-fibrosis disease medicine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4430128A1 (en) *	1994-08-25	1996-02-29	Hoechst Ag	Combination preparation with immunosuppressive, cardiovascular and cerebral effects
US5731339A (en) *	1995-04-28	1998-03-24	Zonagen, Inc.	Methods and formulations for modulating the human sexual response
US5824669A (en) *	1996-03-22	1998-10-20	Nitromed, Inc.	Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders

2003
- 2003-10-21 AU AU2003286555A patent/AU2003286555A1/en not_active Abandoned
- 2003-10-21 WO PCT/US2003/033400 patent/WO2004037183A2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2004037183A2 (en)	2004-05-06
WO2004037183A3 (en)	2004-08-05
AU2003286555A8 (en)	2004-05-13

Similar Documents

Publication	Publication Date	Title
AU2001253565A1 (en)	2001-11-20	Cardiac disease treatment and device
AU2001275176A1 (en)	2001-12-24	Cardiac disease treatment and device
AU5982300A (en)	2001-01-30	Novel methods and medicament for treating infectious diseases involving microbial biofilms
AU2001281369A1 (en)	2002-02-25	Cardiac disease treatment and device
AU2003256253A1 (en)	2003-12-02	Aerosol for medical treatment and methods
AU2002326600A1 (en)	2003-02-24	Side-exit catheter and method for its use
AU2003290548A1 (en)	2004-06-07	Prevention and treatment of synucleinopathic disease
AU2003304386A1 (en)	2005-02-25	Methods for treating and preventing apoptosis-related diseases using rna interfering agents
AU2000260550A1 (en)	2001-10-23	Treatment of skin damage using polyenylphosphatidylcholine
AU5788300A (en)	2001-01-22	Medical treatment method and kit
AU2002254158A1 (en)	2002-09-24	Medical devices, compositions and methods for treating vulnerable plaque
AU2003249716A1 (en)	2004-01-23	Method and system for increasing the efficacy of a clinical trial
AUPR638101A0 (en)	2001-08-09	Composition and method for treatment of disease
AU2002237667A1 (en)	2002-05-27	Methods for the treatment and prevention of urinary stone disease
AU2003286555A1 (en)	2004-05-13	Phosphodiester inhibitors and nitric oxide modulators for treating peyronie's disease, arteriosclerosis and other fibrotic diseases
AU5838700A (en)	2001-02-19	Method for treating and preventing finger disorders
MXPA03003741A (en)	2003-07-28	Methods and compositions for the treatment of diseases of the eye.
MXPA03006776A (en)	2003-10-24	Use of il-18 inhibitors for the treatment and/or prevention of heart disease.
AU2002313364A1 (en)	2003-06-12	Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
AU2002349268A1 (en)	2003-06-26	Medicine for preventing and treating bromidrosis
AU2003237657A1 (en)	2003-12-12	Means and methods for improved treatment using "setrones"
AU2001245414A1 (en)	2001-09-24	Treatment of allergies
ZA200209632B (en)	2004-04-23	Methods for prevention of ulcers and improving physiological performance.
AU2001238288A1 (en)	2001-08-27	Method and compositions for treating fibrotic diseases
AU2002365941A1 (en)	2003-09-02	Methods of diagnosis, monitoring and treatment of fertility

Legal Events

Date	Code	Title	Description
2005-07-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase